Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2493 of 6351
-
Could an epilepsy drug ease stubborn psychosis?
Symptom relief CompletedThis is a 12-week study of levetiracetam added to a second generation antipsychotic in early psychosis patients who have been ill for less than 5 years and continue to experience psychotic symptoms despite at least 8 weeks of antipsychotic treatment. Levetiracetam (Keppra) is a m…
Phase 2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Smartphone prompts timed to mood may boost quitting efforts
Symptom relief CompletedThis study aims to investigate approaches to capitalize on states of vulnerability and receptivity to deliver real-time self-regulation prompts among smokers.
Sponsor: University of Utah • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New HIV prevention pill shows promise in Real-World study
Prevention CompletedSubjects who go to emergency room for possible contact to HIV transmission receive Delstrigo as post exposition prophylaxis.
Phase 4 • Sponsor: Hospital Clinic of Barcelona • Aim: Prevention
Last updated Jun 26, 2026 15:48 UTC
-
New PET tracer could spot hidden cancers
Diagnosis OngoingThis exploratory study investigates how an imaging technique called 68Ga-FAPi-46 PET/CT can determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulates in normal and cancer tissues in patients with cancer. Because some cancers take up 68Ga-FAPi-46 it can be see…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Sickle cell gene therapy trial halted after just 4 patients
Disease control Stopped earlyThis study evaluated a genome-edited, autologous, hematopoietic stem and progenitor cell (HSPC) product - OTQ923 to reduce the biologic activity of BCL11A, increasing fetal hemoglobin (HbF) and reducing complications of sickle cell disease.
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Deeper DNA analysis may unlock better cancer care
Knowledge-focused Recruiting nowThe "simple" analysis of the exome can determine somatic and constitutional mutations. The major challenge lies in the translation of sequencing data into clinically relevant information allowing the clinician to guide his decision-making A "complex" analysis of the exome would p…
Phase 2 • Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Bone loss after bariatric surgery: could denosumab be the answer?
Disease control CompletedBariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for celiac sufferers: drug targets stubborn symptoms
Symptom relief CompletedThis study will evaluate the efficacy and safety of PRV-015 in adult patients with non-responsive celiac disease (NRCD) who are on a gluten-free diet (GFD).
Phase 2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo shows promise for rare autoimmune disease
Disease control CompletedThis is a Phase 2a, multi-center, open-label, two-arm study of approximately 25 patients with active IgG4-related disease (IgG4-RD). The two arms include (1) Experimental: rilzabrutinib with glucocorticoids and (2) Active Comparator: glucocorticoids only.
Phase 2 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a muscle relaxant stop deadly heart rhythms?
Disease control CompletedThis is a randomized, placebo-controlled trial of Dantrolene (N= 84 participants) to demonstrate the feasibility of using intravenous (IV) dantrolene to study the effect of RyR2 inhibition on cardiac electrophysiology, hemodynamics, and ventricular arrhythmia inducibility in pati…
Phase 2/3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Stroke speech therapy: finding the right dose
Symptom relief CompletedAfter a stroke, many people experience a language impairment called aphasia. One of the most debilitating types of aphasia is non-fluent aphasia. Non-fluent aphasia is defined by significantly reduced speech production, with the speaker producing only a few words or even less. Sp…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Acupuncture needles may unlock relief for stubborn neck pain
Symptom relief CompletedThe goal of this clinical trial is to determine whether acupuncture can improve neck pain and shoulder movement in people with chronic neck pain. Researchers will compare acupuncture with sham acupuncture (a procedure designed to resemble acupuncture without therapeutic effects) …
Sponsor: Hualien Tzu Chi General Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a wrap boost finger healing after tendon surgery?
Disease control CompletedTo analyze outcomes between patients with Z2FT injuries following repair, randomized to two groups. The first group will be the negative control, with no tendon wrap. The second group will have a VersaWrap Tendon Protector applied over the site of the tendon repair. VersaWrap is …
Sponsor: University of Florida • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New program aims to get more people screened for colon cancer in appalachia
Prevention CompletedThis project aims to implement a multi-level group randomized trial, delayed intervention that includes components targeting clinics, providers, patients, and the community to increase colorectal cancer (CRC) screening, follow-up, and referral-to-care among patients age 50-74 in …
Sponsor: Mark Dignan, PhD • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
COVID-19 drug trial halted: LAU-7b studied in hospitalized patients
Disease control Stopped earlyA randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patients at a higher risk of complications.
Phase 2/3 • Sponsor: Laurent Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a zapping cap help Alzheimer's patients remember?
Symptom relief OngoingAlzheimer's disease (AD) is the leading neurodegenerative disease of aging characterized by multiple cognitive impairments. Given the recent failures of disease-modifying drugs, the current focus is on preventing or mitigating synaptic damage that correlates with cognitive declin…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New Self-Test could revolutionize cervical cancer screening
Diagnosis CompletedCervical cancer is primarily caused by Human Papillomaviruses (HPV). Testing for HPV in cervical samples is now an option for cervical cancer screening. HPV can also be tested from self-collected samples which may help to improve access to screening, since it does not require a d…
Sponsor: George Washington University • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Peptide vaccine shows promise in head and neck cancer trial
Disease control Stopped earlyThe purpose of this project is to realize a randomized open-label study (EudraCT number: 2020-000120-19) to evaluate the safety and the anti-tumor activity of peptide(s)-based immunotherapy in an umbrella window pre-operative opportunity phase II study in patients with squamous c…
Phase 2 • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Pump up your brain before bypass: study tests Pre-Surgery training to ward off delirium
Prevention Recruiting nowPostoperative delirium (POD) and postoperative cognitive decline (POCD) can be observed after cardiosurgical interventions. Taken together, these postoperative neurocognitive dysfunctions contribute to increased morbidity and mortality and higher economic costs. Preoperative risk…
Sponsor: Heart and Brain Research Group, Germany • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Protein-Packed breast milk could help tiny preemies grow stronger
Disease control OngoingThe central hypothesis of this clinical trial is that, in extremely preterm infants, protein-enriched human milk diets compared to usual human milk diets during the first 2 weeks after birth increase fat-free mass (FFM)-for-age Z scores and promote maturation of the gut microbiom…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC